Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 1985. Upgrade now.
Date Value
December 31, 2023 434.69M
September 30, 2023 1.854B
June 30, 2023 2.033B
March 31, 2023 1.811B
December 31, 2022 1.758B
September 30, 2022 12.74B
June 30, 2022 1.053B
March 31, 2022 2.418B
December 31, 2021 295.22M
September 30, 2021 1.886B
June 30, 2021 1.950B
March 31, 2021 1.479B
December 31, 2020 893.26M
September 30, 2020 1.608B
June 30, 2020 2.806B
March 31, 2020 2.006B
December 31, 2019 1.673B
September 30, 2019 1.912B
June 30, 2019 1.239B
March 31, 2019 1.081B
December 31, 2018 1.563B
September 30, 2018 1.847B
June 30, 2018 600.96M
March 31, 2018 763.39M
December 31, 2017 -725.04M
Date Value
September 30, 2017 1.587B
June 30, 2017 -230.10M
March 31, 2017 1.296B
December 31, 2016 319.24M
September 30, 2016 1.061B
June 30, 2016 -624.85M
March 31, 2016 403.69M
December 31, 2015 -536.96M
September 30, 2015 833.66M
June 30, 2015 228.23M
March 31, 2015 12.26B
December 31, 2014 1.634B
September 30, 2014 669.49M
June 30, 2014 1.101B
March 31, 2014 1.105B
December 31, 2013 3.984B
September 30, 2013 1.503B
June 30, 2013 1.605B
March 31, 2013 1.493B
December 31, 2012 1.361B
September 30, 2012 1.745B
June 30, 2012 1.960B
March 31, 2012 2.055B
December 31, 2011 1.967B
September 30, 2011 2.219B

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

295.22M
Minimum
Dec 2021
12.74B
Maximum
Sep 2022
2.202B
Average
1.811B
Median
Mar 2023

Net Income (Quarterly) Benchmarks

AstraZeneca PLC 960.00M
Haleon PLC -3.726M
Novo Nordisk A/S 3.170B
Pfizer Inc -3.369B
Sanofi SA -597.68M